RxDoctor Payments Data

Raha Mobarak, DPM

Foot & Ankle Surgery · Las Cruces, NMNPI 1275742074

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,800 of the $3,906 with a category attached, or 71.7%. 25 manufacturers reported payments, led by CPM Medical Consultants, LLC at 26.4% of the total. Reporting peaked in 2019 at $1,278 and has fallen 69.5% since, to $390 in 2025.

$3,906in general payments, 2019–2025

Across 92 payments — averaging $42.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CPM Medical Consultants, LLC$1K
  • Stryker$519
  • DJO, LLC$391
  • Kerecis Limited$364
  • Amniox Medical, Inc.$300
  • Smith+Nephew$235
  • plus $1K from 19 others

What the payments were for

  • Consulting fees$3008%
  • Travel & lodging$80621%
  • Food & beverage$2,80072%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,906 in reported general payments places this provider in the 65th percentile of 69 foot & ankle surgery providers in New Mexico.

See all foot & ankle surgery providers in New Mexico

Medicare billing

Part B allowed, 2024
$187,961
Medicare patients
294
Services billed
1,868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Linezolid15$1,305
Gentamicin Sulfate39$1,229
Ketoconazole74$1,157
Gabapentin52$595
Clindamycin Hcl29$403
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav42$333
SsdSilver Sulfadiazine30$292
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim48$287
Doxycycline Hyclate31$277
Ciprofloxacin Hcl28$228
Silver Sulfadiazine26$190
Ampicillin Trihydrate18$160
Hydrocortisone16$154
Cephalexin18$145
Methylprednisolone11$101

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Las Cruces

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →